Day: March 9, 2022

TEMECULA, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is proud to announce yet another expansion of their manufacturing capabilities for the growing Marine market. With this expansion, they have become one of the largest manufacturers providing localized assembly in both Busan Korea and Hangzhou China. This expansion represents their commitment to and support of the growth of the Asian shipbuilding industry.

Their Hangzhou China facilities are now equipped to manufacture and deliver marine skids and provide full integration and assembly in-house. This allows for greater quality control and reduced cost for their customers. The new, larger facility in Korea provides full-system Marine solutions. Together, these facilities now provide full localization for design, engineering and manufacturing.

As a unified Nikkiso Group, they are the only company that offers the core technology components completely in-house. They provide fully integrated turnkey fuel system solutions, cargo handling solutions and complex LNG missions. Through their China facility, they can now offer in-country full string testing and provide full fuel gasket testing to ensure meeting engine requirements. Their service capabilities in China and Korea have also been expanded with additional service offerings, long-term service agreements and more field service specialists.

“We are proud to be helping lead the way in the LNG powered Marine market and providing significant benefits to our Marine customers. Nikkiso CE&IG will now be able to provide complete systems and support our customers with a complete factory supported solution,” according to Peter Wagner, CEO of Cryogenic Industries and President of the Group.

Marine continues to be a major focus of the Group, and this expansion provides a strong support structure for future growth. The locations also eliminate the need for ocean freighting for shipment delivery, resulting in shorter delivery times to their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a part of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Derek Aberle, former President of Qualcomm and Nick Stone, former VP of TPG Capital, are business leaders with extensive experience in technology, driving growth and capital markets

QUEBEC CITY, March 09, 2022 (GLOBE NEWSWIRE) — LeddarTech^®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the appointments of Derek Aberle and Nick Stone to its Board of Directors.

Mr. Derek Aberle’s experience includes senior executive roles in large, global technology companies as well as the investment community. Mr. Aberle spent 17 years at Qualcomm Incorporated, a global leader in mobile and related technologies and products, in a variety of senior executive roles. From 2014 to 2018, he served as President of Qualcomm with responsibility for all business units, including its licensing and semiconductor businesses, as well as its marketing organization and regional offices worldwide. Prior to that, he served as EVP and Group President and as EVP and President of Qualcomm Technology Licensing. He was a member of Qualcomm’s executive committee for over a decade, helping to drive the company’s overall strategy. Mr. Aberle led many of Qualcomm’s global growth initiatives, including in markets beyond smartphones as well as its expansion in China. He also led Qualcomm’s technology and IP licensing business through a period of tremendous growth and profitability, established its 4G and 5G licensing programs, and structured and negotiated Qualcomm’s major license and other strategic agreements. Since leaving Qualcomm Mr. Aberle co-founded XCOM Labs, a company focused on developing and commercializing advanced wireless technologies, and presently serves as Executive Vice Chairman of XCOM Labs. He also is the CEO of Prospector Capital Corp., a special purpose acquisition company.

Mr. Aberle holds a B.A. in business economics from the University of California, Santa Barbara and a J.D. from the University of San Diego School of Law. He is a board member for XCOM Labs, Prospector Capital Corp., Jaws Juggernaut Acquisition Corp., the Alliance for SoCal Innovation and EvoNexus (a Southern California incubator).

Mr. Nick Stone possesses over 20 years of experience in the investment industry and has been partner with FS Investors since 2010. He previously served as Vice President of TPG Capital, one of the world’s largest private equity funds and an investment professional with Kohlberg Kravis Roberts Co. and Morgan Stanley. As a result, Mr. Stone brings a wealth of knowledge in finance, global markets and high-level investing. He has been involved in investments totaling $20 billion and approximately $2.5 billion in equity capital during his successful career.

Mr. Stone graduated cum laude from Harvard, was an Arjay Miller Scholar at the Stanford Graduate School of Business and resides in La Jolla, California.

“I am very proud to welcome Derek and Nick,” stated Mr. Michel Brûlé, Chairman of the Board of Directors of LeddarTech. “Our Board is comprised of an exceptional group of highly skilled and experienced leaders representing different industries and fields of expertise, including former senior managers and CEOs of companies such as Bosch, Texas Instruments, NXP, Tata Motors, GM, Faurecia, Geely, BMW and the Business Development Bank of Canada.” Mr. Brûlé continued: “The addition of Derek and Nick with their vast experience in technology, global markets and finance will even further enhance the Board’s expertise as well as strengthen our ability to accelerate the growth and success of LeddarTech,” concluded Mr. Brûlé.

“We are privileged to welcome Derek and Nick to our Board,” stated Mr. Charles Boulanger, CEO of LeddarTech. “There’s no doubt that our company’s leadership will be enhanced by Derek’s executive background in the technology industry, specifically in driving global strategies, expertise in international markets, artificial intelligence and wireless technology, and by Nick’s decades of experience in the financial markets where he has led key investments across numerous sectors and geographies,” added Mr. Boulanger. “Adding such exceptional, well respected individuals to our Board of Directors will undoubtedly build the momentum towards the advancement of our ambitious strategic objectives,” concluded Mr. Boulanger.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2+ ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LiDAR XLRator™, a development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™ and core components from global semiconductor partners. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 100 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/509e1e00-3336-4581-acf4-69895b4cc0db

Chip Wilson suffers from a rare form of muscular dystrophy and seeks scientific innovators to find a cure to help him and others

VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — The world’s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend their successes to optimistically forge a path to overcome one’s biggest challenge – their health.

Going public with his own story, Wilson, who was diagnosed with Facioscapulohumeral muscular dystrophy type 2 (FSHD2) at age 32, announced he has committed $100 million and created a new venture, Solve FSHD, with the objective of finding a cure for FSHD by 2027, targeting the underlying genetic cause or improving muscle function and growth.

“Solve FSHD will accelerate the underfunded development of drugs and therapies to stop muscle degeneration, increase muscle strength and improve the quality of life for those living with this,” said Wilson, who stopped playing squash 10 years ago because he could no longer lift a racquet over his head.

At 67, the serial entrepreneur and father of five boys says his upper body is “very wasted.” His legs have lost significant muscle tissue and Wilson can see a time in the not-so-distant future when he will need the assistance of a wheelchair.

“I can still walk, but I must be very intentional and present, or I will trip and fall. I do see a day when I will be unable to walk on my own,” said the Canadian entrepreneur and venture philanthropist. Currently, there is no cure for FSHD, a genetic disorder that has varying symptoms, severity, and progression. According to the Mayo Clinic, muscle weakness usually starts in the face, hip and shoulders. Onset usually occurs in the teenage years but can begin in childhood.

“It’s one of the most prevalent adult muscular dystrophies. The investments of Solve FSHD now to help validate biomarkers and develop new therapies will pay dividends later for any company or researcher pursuing better therapies for FSHD. These investments form the foundation to support future clinical trials and serve as a seed for further funding and investment,” adds Dr. Jeffrey Statland, Assistant Professor of Neurology at the University of Kansas Medical Center. Dr. Statland has conducted clinical and research training in neuromuscular diseases, with a primary interest in FSHD.

“Solve FSHD will support projects that normally wouldn’t receive funding, including bottlenecks in the pipeline and thereby accelerating the development of clinical trials and novel therapies. We can move quickly and pursue multiple projects simultaneously,” Wilson said.

Scientists, biotech and biopharma companies, muscular degeneration specialists and other researchers working in similar muscular dystrophy fields are all encouraged to contact Solve FSHD. Solve FSHD is seeking to fund or invest in potential research partners, companies, and clinicians interested in advancing related research and clinical trials.

Solve FSHD also wants to hear from those with FSHD or who suspect they may have it, who can help by volunteering to join a contact registry for clinical trials.

“FSHD is life-altering and I know my future will be challenging,” said Wilson. “I prefer not to sit in the stands but go out on the courts with my time and money to help this important cause so very close to my heart. In this way, there is something to smile about for those touched by FSHD.”

About Solve FSHD
Solve FSHD is funding innovative biotech and biopharma research and development activities that accelerate novel treatments of Facioscapulohumeral muscular dystrophy (FSHD) treatment. It is fully funded and created by Canadian entrepreneur and philanthropist Chip Wilson. The founder of yoga-inspired athletic apparel company Lululemon Athletica inc. has been living with FSHD for the last three decades of his life. He has committed $100 million of his own money to create Solve FSHD and kick-start funding into projects that fit the organization’s mission: accelerate research into new therapies and find a cure for the disorder by 2027.

Future announcements for grant funding will be issued on Solve FSHD’s website – https://solvefshd.com/

For early-stage companies, contact Solve FSHD at info@solvefshd.com.

If you have FSHD and want to find out about clinical trials or be included in the FSHD registry, please see Solve FSHD’s website – https://solvefshd.com/

For media inquiries or to request a media interview, please contact:
Kamran Shaikh, Account Director
PR Associates
kshaikh@prassociates.com
778-846-5406